ראשי » פרוטוקול » A Phase II Study to Assess the Ability of Neoadjuvant Chemotherapy +/- Second Look Surgery to Eliminate All Measurable Disease Prior to Radiotherapy for NGGCT

A Phase II Study to Assess the Ability of Neoadjuvant Chemotherapy +/- Second Look Surgery to Eliminate All Measurable Disease Prior to Radiotherapy for NGGCT

CHILDREN'S ONCOLOGY GROUP
ACNS0122

A Groupwide Phase II Study
Target Tumors
Non-Germinomatous Germ Cell Tumors

STUDY CHAIR:
Stewart Goldman, MD

חייבים להתחבר כדי להגיב.

נותנות החסות לאיגוד: